BD (NYSE: BDX) is touting that it is the first medical technology company authorized as a Common Vulnerability and Exposures (CVE) Numbering Authority by the CVE Program. BD officials say the authorization further boosts the company’s healthcare cybersecurity leadership. Get the full story on our sister site Medical Design & Outsourcing.
Mitre
FDA partners with Mitre to beef up med device cybersecurity
The FDA said Monday it is teaming up with non-profit, federally funded R&D group Mitre to develop a “more collaborative approach” to cybersecurity vulnerabilities. Mitre and FDA director of emergency preparedness, operations and medical countermeasures Dr. Suzanne Schwartz are slated to present on “Systemic management of medical device cybersecurity” at the health IT conference HIMSS16 […]